Healthcare entity
All 1 tracked stories fall under one category: regulation. Justice Sachin Datta is most often covered alongside Central Drugs Standard Control Organisation (CDSCO), which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline.
Last mentioned: Mar 18, 2026
Entity pulse
Coverage balance Negative coverage leads. Negative coverage exceeds positive coverage by 100 percentage points.
Figures are computed live from our source-verified story record — see our methodology for how impact and sentiment are derived.
All 1 tracked stories fall under one category: regulation. Justice Sachin Datta is most often covered alongside Central Drugs Standard Control Organisation (CDSCO), which appears in 1 of these 1 story. Source depth averages 2 original sources per story, versus 2.5 across the same-window beat baseline. Their average consequence score of 6 runs above the beat's 5.8 for that window. We currently track 1 Healthcare story that mention Justice Sachin Datta, all published on March 18, 2026.
Computed from the 1 stories linked to this entity, with beat comparisons drawn from all 24 Healthcare stories published in the same date window. Shares are omitted below five stories and comparisons below a twenty-story baseline.
Coverage cohort
Other entities that clear the same relevance threshold in stories also covering Justice Sachin Datta. Shared-story counts are live from our verified record — not editorial picks.
Contempt Notice Issued
Justice Sachin Datta issues formal notice to CDSCO seeking an explanation for the delay.
Contempt Petition Filed
Petitioners move court alleging CDSCO failed to meet the review deadline.
Initial Court Order
Delhi HC directs CDSCO to evaluate safety of diabetes drugs for weight loss.
The Delhi High Court has issued a contempt notice to India's drug regulator, CDSCO, for failing to comply with judicial orders to evaluate the safety of diabetes drugs used off-label for weight loss. This escalation signals a growing legal intolerance for regulatory delays amidst a global surge in GLP-1 receptor agonist demand.
Justice Sachin Datta is linked from 1 story on this site, each scored at or above our 35% relevance threshold — see how these pages are built.
See something wrong on this page — a misattributed entity, a wrong stat, a broken source link? Report a data issue.
